Immunoregulatory Soluble CTLA-4 Modifies Effector T-Cell Responses in Systemic Lupus Erythematosus

Arthritis Research & Therapy
doi 10.1186/s13075-016-1075-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Alterations in Immunoregulatory T Cell Subsets in Active Systemic Lupus Erythematosus.

Journal of Clinical Investigation
Medicine
1980English

The Soluble Isoform of CTLA-4 Correlates With Interferon-Α Activity in Systemic Lupus Erythematosus

Journal of Rheumatology
RheumatologyAllergyImmunology
2019English

T Cell Transcriptomes Describe Patient Subtypes in Systemic Lupus Erythematosus

PLoS ONE
Multidisciplinary
2015English

Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus

Journal of Immunology
AllergyImmunology
2005English

Systemic Lupus Erythematosus

JAMA - Journal of the American Medical Association
Medicine
2011English

CTLA-4 Antibody Ipilimumab Negatively Affects CD4+ T-Cell Responses in Vitro

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2019English

Systemic Lupus Erythematosus

Deutsche Medizinische Wochenschrift
Medicine
2005English

Systemic Lupus Erythematosus

Clinical and Developmental Immunology
2012English

B Cell Lymphokines in Human Systemic Lupus Erythematosus.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy